Derivative exercise or conversion — not an open-market buy.
Loading…
Adam Keeney is Head of Corporate Development at Biogen. OQRO lists 10 transactions filed with the SEC under this name, the latest on May 5, 2026, each linked to the official Form 4.
Head of Corporate Development
Disclosures on record
10
Companies involved
1
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.